tRNA-derived fragments: mechanism of gene regulation and clinical application in lung cancer
Cellular Oncology · 2024-02 · 47 (1) · 37-54
DOI: 10.1007/s13402-023-00864-z ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Cellular Oncology, online erschienen am 29.08.2023. Verfasst von Fan Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Lab for Noncoding RNA & Cancer, School of Life Sciences, Shanghai University, 381 Nanchen Road, Shanghai, 200444, China. Hauptthemen laut MEDLINE: Lung Neoplasms, RNA, Transfer, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Shanghai Science and Technology Committee, Yunnan Provincial Science and Technology Department - Kunming Medical University Joint Fund Key Project.
Abstract (Originalsprache)
Lung cancer, being the most widespread and lethal form of cancer globally, has a high incidence and mortality rate primarily attributed to challenges associated with early detection, extensive metastasis, and frequent recurrence. In the context of lung cancer development, noncoding RNA molecules have a crucial role in governing gene expression and protein synthesis. Specifically, tRNA-derived fragments (tRFs), a subset of noncoding RNAs, exert significant biological influences on cancer progression, encompassing transcription and translation processes as well as epigenetic regulation. This article primarily examines the mechanisms by which tRFs modulate gene expression and contribute to tumorigenesis in lung cancer. Furthermore, we provide a comprehensive overview of the current bioinformatics analysis of tRFs in lung cancer, with the objective of offering a systematic and efficient approach for studying the expression profiling, functional enrichment, and molecular mechanisms of tRFs in this disease. Finally, we discuss the clinical significance and potential avenues for future research on tRFs in lung cancer. This paper presents a comprehensive systematic review of the existing research findings on tRFs in lung cancer, aiming to offer improved biomarkers and drug targets for clinical management of lung cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Lab for Noncoding RNA & Cancer, School of Life Sciences, Shanghai University, 381 Nanchen Road, Shanghai, 200444, China.
- Lab for Noncoding RNA & Cancer, School of Life Sciences, Shanghai University, 381 Nanchen Road, Shanghai, 200444, China. zlma@shu.edu.cn.
- Department of Thoracic Surgery, The Third Affiliated Hospital of Kunming Medical University, Cancer Hospital, Yunnan Cancer Center, Kunming, 650118, China. wangweiweiqj@126.com.
Förderung
- Shanghai Science and Technology Committee
- Yunnan Provincial Science and Technology Department - Kunming Medical University Joint Fund Key Project
Zitieren
APA
Wu, F., Yang, Q., Pan, W., Meng, W., Ma, Z., & Wang, W. (2024). tRNA-derived fragments: mechanism of gene regulation and clinical application in lung cancer. Cellular Oncology, 47(1), 37-54. https://doi.org/10.1007/s13402-023-00864-z
Vancouver
Wu F, Yang Q, Pan W, Meng W, Ma Z, Wang W. tRNA-derived fragments: mechanism of gene regulation and clinical application in lung cancer. Cellular Oncology. 2024;47(1):37-54. doi:10.1007/s13402-023-00864-z
BibTeX
@article{Wu2024,
author = {Wu, Fan and Yang, Qianqian and Pan, Wei and Meng, Wei and Ma, Zhongliang and Wang, Weiwei},
title = {tRNA-derived fragments: mechanism of gene regulation and clinical application in lung cancer},
journal = {Cellular Oncology},
year = {2024},
volume = {47},
number = {1},
pages = {37--54},
doi = {10.1007/s13402-023-00864-z}
}
EUVIMED